UNICA IRIS Institutional Research Information System

MELONI, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 65.179
NA - Nord America 2.377
AS - Asia 1.107
SA - Sud America 153
Continente sconosciuto - Info sul continente non disponibili 96
AF - Africa 44
OC - Oceania 26
Totale 68.982
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 64.539
US - Stati Uniti d'America 2.295
SG - Singapore 399
CN - Cina 322
SE - Svezia 157
BR - Brasile 122
GB - Regno Unito 101
VN - Vietnam 96
DE - Germania 87
FR - Francia 60
CA - Canada 54
FI - Finlandia 46
IN - India 43
KR - Corea 41
UA - Ucraina 39
HK - Hong Kong 37
NL - Olanda 27
AU - Australia 22
ES - Italia 22
TW - Taiwan 22
JP - Giappone 19
TR - Turchia 19
IQ - Iraq 17
IR - Iran 16
RO - Romania 14
ZA - Sudafrica 14
AT - Austria 13
PH - Filippine 13
IE - Irlanda 12
MX - Messico 12
MY - Malesia 10
RU - Federazione Russa 10
AR - Argentina 9
CZ - Repubblica Ceca 8
EG - Egitto 8
PL - Polonia 8
SA - Arabia Saudita 8
VE - Venezuela 8
CH - Svizzera 6
IL - Israele 6
KE - Kenya 6
BD - Bangladesh 5
BE - Belgio 5
MA - Marocco 5
TH - Thailandia 5
ET - Etiopia 4
JM - Giamaica 4
LB - Libano 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
PT - Portogallo 4
RS - Serbia 4
TN - Tunisia 4
UZ - Uzbekistan 4
AL - Albania 3
GR - Grecia 3
ID - Indonesia 3
LV - Lettonia 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BG - Bulgaria 2
CL - Cile 2
CO - Colombia 2
CR - Costa Rica 2
EC - Ecuador 2
JO - Giordania 2
MT - Malta 2
NP - Nepal 2
PE - Perù 2
UY - Uruguay 2
AM - Armenia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
EU - Europa 1
GD - Grenada 1
GP - Guadalupe 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TC - Turks e Caicos 1
TT - Trinidad e Tobago 1
Totale 68.887
Salva come PNG Salva come JPEG
Città #
Cagliari 63.383
Uta 876
Ashburn 280
Singapore 227
Chandler 158
San Jose 145
Fairfield 117
Nyköping 97
Dallas 86
Boardman 85
Beijing 75
New York 71
Woodbridge 60
Houston 57
Shanghai 54
Augusta 52
Seattle 52
Los Angeles 50
Wilmington 49
Ann Arbor 48
Santa Clara 45
Cambridge 37
Helsinki 37
Seoul 37
Dearborn 36
Ho Chi Minh City 31
Council Bluffs 30
Redwood City 30
Hong Kong 28
The Dalles 28
Hanoi 24
Lauterbourg 22
São Paulo 22
Jacksonville 20
Boston 18
Atlanta 17
Frankfurt am Main 17
Buffalo 16
London 16
Orem 14
Munich 13
Denver 12
Dublin 12
Phoenix 12
Stockholm 12
Tokyo 12
Amsterdam 11
Baghdad 11
Finale Ligure 11
Hefei 11
Toronto 11
Chennai 10
Chicago 10
Glasgow 10
Guangzhou 10
Manchester 10
San Mateo 10
Milan 9
Syracuse 9
Brooklyn 8
Montreal 8
Rome 8
San Francisco 8
Tramatza 8
Vienna 8
Changsha 7
Curitiba 7
Dolianova 7
Nanjing 7
Nottingham 7
San Diego 7
Taipei 7
Bacolod City 6
Cairo 6
Central 6
Düsseldorf 6
Falls Church 6
Istanbul 6
Johannesburg 6
Mumbai 6
Nuremberg 6
Paris 6
Richmond 6
Rio de Janeiro 6
Sydney 6
Bangkok 5
Brno 5
Bucharest 5
Cape Town 5
Haiphong 5
Melbourne 5
Perham 5
Shenyang 5
Washington 5
Auburn 4
Cagayan de Oro 4
Da Nang 4
Edgemont 4
Falkenstein 4
Galatina 4
Totale 66.997
Salva come PNG Salva come JPEG
Nome #
Efficacy and safety of the 5-Hydroxytryptophan on Levodopa-Induced Motor Complications in Parkinson's disease 24.362
C9ORF72 intermediate repeat expansion in patients affected by atypical Parkinsonian syndromes or parkinson’s disease complicated by psychosis or dementia in a Sardinian population 4.298
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 4.095
Efficacy and safety of the 5-Hydroxytryptophan on Depression and Apathy in Parkinson's disease: a preliminary finding 3.355
Pisa-Like Syndrome Under Baclofen in a Patient With Spastic Hemiparesis due to Ischemic Stroke 3.189
Focal 123I-FP-CIT SPECT abnormality in a patient with midbrain vascular Parkinsonism 3.137
Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding 2.385
Efficacy and Safety of the 5-Hydroxytryptophan on REM Sleep Behavior Disorder in Parkinson's Disease 2.280
Severity of REM sleep without atonia (RSWA) correlates with cognitive functions in patients with REM sleep behaviour disorder (RBD) 2.226
Efficacy and safety of the 5-Hydroxytryptophan on Depression and Apathy in Idiopathic Parkinson's disease 2.175
Neuropsychological and behavioral profile of patients with isolated REM sleep behaviour disorders (iRBD) and patients with RBD associated with Parkinson's Disease (PDRBD) 2.139
Association between dopaminergic medications and REM sleep behavior disorder in Parkinson’s disease: a preliminary cohort study 1.769
Does REM sleep behavior disorder change in the progression of Parkinson’s disease? 1.711
Diagnosing REM sleep behavior disorder in Parkinson's disease without a gold standard: a latent-class model study 1.528
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Safety and Efficacy of the 5-Hydroxytryptophan on REM Sleep Behavior Disorder, Levodopa-Induced Motor Complications and Neuropsychiatric Disorders in Idiopathic Parkinson's disease. 1.526
DIAGNOSING REM SLEEP BEHAVIOUR DISORDER IN PARKINSON DISEASE WITHOUT A GOLD STANDARD: A LATENT CLASSES MODELS STUDY 1.377
Does REM Sleep Behavior Disorder Change in the Progression of Parkinson’s Disease? 1.363
REM sleep behavior disorder changes in the progression of Parkinson's disease: a longitudinal study 1.348
Cognitive and Behavioral features of isolated Rem Sleep Bhaviour disorders (IRBD) and RBD associated with Parkinson's disease (PDRBD 1.061
Preliminary finding of a randomized, double-blind, placebo-controlled, crossover study to evaluate the safety and efficacy of 5-hydroxytryptophan on REM sleep behavior disorder in Parkinson's disease 1.044
Neurophysiological features of REM sleep Behaviour Disorder (RBD) correlate with cognitive and psycho-behavioral profile 973
Severity of REM sleep without atonia correlates with measures of cognitive impairment and depressive symptoms in REM sleep behaviour disorder 601
Considering REM Sleep Behavior Disorder in the Management of Parkinson's Disease 534
Oligomeric Alpha-Synuclein and STX-1A from Neural-Derived Extracellular Vesicles (NDEVs) as Possible Biomarkers of REM Sleep Behavior Disorder in Parkinson's Disease: A Preliminary Cohort Study 429
Oligomeric α-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms 77
Totale 68.982
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.571
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.571
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.169 0 0 0 143 214 288 281 126 181 297 269 370
2022/20233.611 366 509 495 325 317 280 171 214 215 218 348 153
2023/20243.703 119 129 140 250 356 519 551 253 146 240 460 540
2024/202528.284 12.124 4.952 9.001 692 375 367 409 61 95 63 71 74
2025/20261.803 201 73 157 178 152 164 333 105 153 179 68 40
2026/2027505 44 233 137 91 0 0 0 0 0 0 0 0
Totale 68.982